Delivery Order SPE2DB22D2206-SPE2DB23FKP55
Award Date 9/27/23
Potential Completion Date 10/19/23
Potential Value $7.5K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency Troop Support Medical awarded a $29,939 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 125 mg tablets of IBRANCE to be delivered to its Conshohocken, Pennsylvania facility. As a major pharmaceutical distributor, Amerisourcebergen will supply 756 tablets of the cancer drug under the contract. The Defense Logistics Agency manages the Department of Defense's global supply chain and is responsible for procuring medical supplies and...
- The Defense Logistics Agency Troop Support Medical awarded a $7,488.80 firm fixed price delivery order to Amerisourcebergen Drug Corporation for IBRANCE 100 MG tablets. The delivery order was issued against an existing Prime Vendor contract vehicle to supply pharmaceutical products and services to DLA customers. Amerisourcebergen will deliver 7 boxes of the tablets to a facility in Conshohocken, Pennsylvania by September 6th, 2023. No subcontractors or set aside designations were identified....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,236.16 to AmerisourceBergen Drug Corp for the supply of Ibrance 125 mg tablets (7-count units) on August 25, 2025, with completion scheduled for September 16, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,122.48 for the supply of Ibrance 100 mg tablets (7-day supply) under a firm fixed price contract. The award was made on August 5, 2025, with an ultimate completion date of August 26, 2025. This is an unset-aside, competitively awarded delivery order executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $8,123.96 on June 9, 2025, for the supply of Ibrance 75 mg tablets (quantity 7 units). This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 1, 2025. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,559.84 to AmerisourceBergen Drug Corp for the supply of Ibrance 100 mg tablets (7-count units) under a firm fixed price contract. The delivery order was competitively awarded without set-aside designation, with performance to be completed by January 22, 2026. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical supply contract, which supports federal...
- The Defense Logistics Agency awarded a $8,118.08 firm fixed price delivery order to AmerisourceBergen Drug Corp for Ibrance 125 mg tablets on July 17, 2025, with an ultimate completion date of August 7, 2025. This competitively awarded, non-set-aside contract calls for delivery to AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. This delivery...
- The Defense Logistics Agency awarded a $15,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 21 capsules of the pharmaceutical IBRANCE (palbociclib) to support the agency's medical supply needs. As a major distributor of pharmaceuticals and medical supplies for the Department of Defense, Amerisourcebergen will deliver the ordered products from its facility in Conshohocken, Pennsylvania to an unspecified location by August 2, 2023 to fulfill requirements under the...
- The Defense Logistics Agency awarded a $44,932.80 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 21 capsules of the pharmaceutical IBRANCE (palbociclib) 100 mg. The order is to be fulfilled by Amerisourcebergen from its facility located in Conshohocken, Pennsylvania by September 12, 2023 in support of DLA's medical supply procurement programs. As a top 10 federal contractor, Amerisourcebergen has extensive experience providing pharmaceuticals and medical supplies under...
- The Defense Logistics Agency awarded a $16,247.92 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Ibrance 75 mg capsules (quantity 21). This is a non-set-aside competitive award with an ultimate completion date of October 10, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB23FKP55Delivery Order
The Defense Logistics Agency awarded a $7,488.80 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 100 mg IBRANCE tablets. Under this order, Amerisourcebergen will deliver 7 boxes of the cancer treatment drug to a facility in Conshohocken, Pennsylvania by October 19th to support the DLA's medical supply chain operations. As a top pharmaceutical distributor, Amerisourcebergen routinely fulfills delivery orders under the DLA's Prime Vendor contracts to provide medical supplies to military treatment facilities worldwide. No subcontractors or set aside designations were specified for this particular order.
Generated 12/27/23, 9:13 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.5k | 9/27/23 |